Search Follow us

Healthcare sector team

Analysts

Dr Nathaniel Calloway

Dr Nathaniel Calloway
Associate Healthcare Analyst

Pooya Hemami

Pooya Hemami
Analyst

Dr Dennis Hulme

Dr Dennis Hulme
Analyst

Maxim Jacobs

Maxim Jacobs
Director of Healthcare Research, North America

Dr Susie Jana

Dr Susie Jana
Analyst

Alice Nettleton

Alice Nettleton
Healthcare Analyst

Dr Jonas Peciulis

Dr Jonas Peciulis
Analyst

Dr John Savin

Dr John Savin
Analyst

Juan Pedro Serrate

Juan Pedro Serrate
Associate Analyst

Andy Smith

Andy Smith

Briana Warschun

Briana Warschun
Associate Healthcare Analyst

Dr Daniel Wilkinson

Dr Daniel Wilkinson
Analyst

By region

Recent initiations

Cantargia InMed Pharmaceuticals
Immunicum ASIT Biotech
Oncology Venture Adocia

Recent QuickViews

Antibe Therapeutics

Working towards a GI-safe NSAID drug

Pharmaceutical & healthcare | published 14/06/2018
Avivagen

Antibiotic-free alternative for animal feed

Pharmaceutical & healthcare | published 12/06/2018
Acerus Pharmaceuticals

Growing Canadian specialty pharma business

Pharmaceutical & healthcare | published 11/06/2018
CannTrust Holdings

Capitalising on medical cannabis opportunity

Pharmaceutical & healthcare | published 16/05/2018

Would you like to be notified when new research is published? Access our research RSS feed

Latest research

Orexo

EU launch milestone achieved

Update | Pharmaceutical & healthcare | 19/06/2018

Yesterday Orexo announced the launch of Zubsolv in the EU by its partner Mundipharma, triggering a €3m (c SEK30.6m) milestone payment. Zubsolv is…

Abzena

FY18 results – clouds lifting

Update | Pharmaceutical & healthcare | 19/06/2018

Following a stronger H2 and Abzena’s FY18 results, we have made major changes to our model across both the services business and the Abzena Inside…

Atossa Genetics

Atossa raises $13.4m in rights offering

Update | Pharmaceutical & healthcare | 15/06/2018

Atossa’s previously announced rights offering closed on 30 May 2018, generating $13.3m in gross proceeds ($12.1m net) through the issue of 13,324…

Targovax

FOLFIRINOX sets bar in pancreatic cancer high

Update | Pharmaceutical & healthcare | 13/06/2018

On 12 June, Targovax announced a strategic decision to move away from developing TG01, a neoantigen cancer vaccine for resected pancreatic cancer after…

TxCell

Lonza to make CAR Tregs

Update | Pharmaceutical & healthcare | 12/06/2018

TxCell has announced that Lonza, the biopharmaceutical and cell manufacturing global specialist, will produce its CAR Tregs. TxCell uses a robust manufacturing…

Sector commentary

See more reports See more reports See more reports

Sector reports

See more sector reports See more sector reports See more sector reports

Sectors covered

Pharmaceutical & healthcare Show companies